Sona Nanotech Inc. is pleased to advise that it has appointed Dr. Carman Giacomantonio MD, MSc., FRCSC to be the Company s Chief Medical Officer. Dr. Giacomantonio is a practicing Surgical.
Sona Nanotech Inc. announces further results from the triple negative breast cancer murine model portion of its current research study at Dalhousie University which confirms that the previously.
Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Sona Nanotech Inc.: Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Sona Nanotech Inc. announces positive interim results from its study with The Giacomantonio Immuno-Oncology Research Group at Dalhousie University . An update received by the Company indicates.